Skip to main content
SpringerLink
Log in

Ethnic and geographic variations in corpus uteri cancer burden: evidence based on data from 29 states and the District of Columbia. CI5 IX, X and SEER data (1998–2010)

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

To assess the pattern of corpus uteri cancer (CUC) in individual states of the USA according to ethnicity.

Methods

Population-based cancer registries from 29 states and the District of Columbia with information on ethnicity for African-American women (AA) and Caucasian-American women (CA) were extracted from the Cancer Incidence in Five Continents (1998–2002, 2003–2007) and the Surveillance, Epidemiology, and End Results Program (SEER; 2008–2010) databases. Rate ratios (RRs) were calculated with respect to ethnicity, age, state, and region.

Results

In southern states, AA had a lower CUC burden among women aged <60 years (AA/CA RR = 0.67; 95 % CI 0.64–0.70), whereas it was higher among women aged ≥60 years (AA/CA RR = 1.22; 95 % CI 1.19–1.26). In other regions, the lower CUC burden among AA aged <60 years was true in all states; however, the CUC burden among AA aged ≥60 years was similar to that of CA. Data for the most recent period (2008–2010) indicate that the age-dependent crossover in CUC burden was not anymore restricted to the South, but also occurred in other regions. Overall, women in the South have had the lowest CUC burden compared with that in all other regions, irrespective of ethnicity and age.

Conclusions

Significant geographic and ethnic variations in the CUC burden exist in the USA. The incidence of hysterectomy could be a factor underlying the geographic variations in CUC burden and particular attention should be given to older AA in southern states.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Shingleton HM, Fowler WC, Jordan JA, Lawrence WD (1996) Gynecologic oncology: current diagnosis and treatment. W. B. Saunders, London

    Google Scholar 

  2. Platz CE, Benda JA (1995) Female genital tract cancer. Cancer 75:270–294

    Article  CAS  PubMed  Google Scholar 

  3. Aziz H, Hussain F, Edelman S et al (1996) Age and race as prognostic factors in endometrial carcinoma. Am J Clin Oncol 19:595–600

    Article  CAS  PubMed  Google Scholar 

  4. Connell PP, Rotmensch J, Waggoner SE, Mundt AJ (1999) Race and clinical outcome in endometrial carcinoma. Obstet Gynecol 94:713–720

    Article  CAS  PubMed  Google Scholar 

  5. Brinton LA, Felix AS, McMeekin DS et al (2013) Etiologic heterogeneity in endometrial cancer: evidence from a gynecologic oncology group trial. Gynecol Oncol 129:277–284

    Article  PubMed Central  PubMed  Google Scholar 

  6. Byers TE, Wolf HJ, Bauer KR et al (2008) The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 113:582–591

    Article  PubMed  Google Scholar 

  7. Clegg LX, Reichman ME, Miller BA et al (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 20:417–435

    Article  PubMed  Google Scholar 

  8. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB (2004) Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health 94:2104–2111

    Article  PubMed Central  PubMed  Google Scholar 

  9. Niu X, Pawlish KS, Roche LM (2010) Cancer survival disparities by race/ethnicity and socioeconomic status in New Jersey. J Health Care Poor Underserved 21:144–160

    Article  PubMed  Google Scholar 

  10. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10–17

    Article  CAS  PubMed  Google Scholar 

  11. Kurman RJ, Zaino RJ, Norris HJ (1994) Endometrial carcinoma. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract. Springer, New York, pp 439–486

    Chapter  Google Scholar 

  12. Ali AT (2013) Risk factors for endometrial cancer. Ceska Gynekol 78:448–459

    PubMed  Google Scholar 

  13. Sonoda Y, Barakat RR (2006) Screening and the prevention of gynecologic cancer: endometrial cancer. Best Pract Res Clin Obstet Gynaecol 20:363–377

    Article  PubMed  Google Scholar 

  14. Yang HP, Wentzensen N, Trabert B et al (2013) Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP diet and health study. Am J Epidemiol 177:142–151

    Article  PubMed Central  PubMed  Google Scholar 

  15. Anonymous(2009) Differences in prevalence of obesity among black, white, and Hispanic adults—United States, 2006–2008. MMWR Morb Mortal Wkly Rep 58: 740–4

  16. Tinelli A, Vergara D, Martignago R, Leo G, Malvasi A, Tinelli R (2008) Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review. Acta Obstet Gynecol Scand 87:1101–1113

    Article  PubMed  Google Scholar 

  17. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19:3119–3130

    Article  CAS  PubMed  Google Scholar 

  18. Smith RA, Cokkinides V, Brawley OW(2012) Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin

  19. Smith RA, Manassaram-Baptiste D, Brooks D et al (2014) Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 64:30–51

    Article  PubMed  Google Scholar 

  20. Segi M (1960) Cancer mortality for selected sites in 24 Countries. In: Sendai, Tohoku (eds) University School of Public Health, 1950–1957

  21. International Agency for Research on Cancer (1991) Cancer registration principles and methods. IARC Press, Lyon

    Google Scholar 

  22. Sighoko D, Kamate B, Traore C et al (2013) Breast cancer in pre-menopausal women in West Africa: analysis of temporal trends and evaluation of risk factors associated with reproductive life. Breast 22:828–835

    Article  PubMed  Google Scholar 

  23. Griffiths CL, Olin JL (2012) Triple negative breast cancer: a brief review of its characteristics and treatment options. J Pharm Pract 25:319–323

    Article  PubMed  Google Scholar 

  24. Sturtz LA, Melley J, Mamula K, Shriver CD, Ellsworth RE (2014) Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer. BMC Cancer 14:62

    Article  PubMed Central  PubMed  Google Scholar 

  25. Sparano JA, Wang M, Zhao F et al (2012) Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst 104:406–414

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250–263

    Article  PubMed Central  PubMed  Google Scholar 

  27. Ali AT (2014) Reproductive factors and the risk of endometrial cancer. Int J Gynecol Cancer 24:384–393

    Article  PubMed  Google Scholar 

  28. Amankwah EK, Friedenreich CM, Magliocco AM et al (2013) Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype. Am J Epidemiol 177:1378–1387

    Article  PubMed Central  PubMed  Google Scholar 

  29. Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31:2607–2618

    Article  PubMed Central  PubMed  Google Scholar 

  30. Brett KM, Chong Y (2011) Hormone replacement therapy knowledge and use in the United States, N.C.f.H. Statistics. CDC, Hyattsville

    Google Scholar 

  31. Brown AF, Perez-Stable EJ, Whitaker EE et al (1999) Ethnic differences in hormone replacement prescribing patterns. J Gen Intern Med 14:663–669

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Alektiar KM, Venkatraman E, bu-Rustum N, Barakat RR (2003) Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer 98:2368–2377

    Article  PubMed  Google Scholar 

  33. Olson SH, Atoria CL, Cote ML et al (2012) The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev 21:753–760

    Article  PubMed  Google Scholar 

  34. Wright JD, Fiorelli J, Schiff PB et al (2009) Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer 115:1276–1285

    Article  PubMed  Google Scholar 

  35. Kjerulff KH, Guzinski GM, Langenberg PW, Stolley PD, Moye NE, Kazandjian VA (1993) Hysterectomy and race. Obstet Gynecol 82:757–764

    CAS  PubMed  Google Scholar 

  36. Sherman ME, Carreon JD, Lacey JV Jr, Devesa SS (2005) Impact of hysterectomy on endometrial carcinoma rates in the United States. J Natl Cancer Inst 97:1700–1702

    Article  PubMed  Google Scholar 

  37. Siegel RL, Devesa SS, Cokkinides V, Ma J, Jemal A (2013) State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004–2008. Cancer Epidemiol Biomarkers Prev 22:25–31

    Article  PubMed Central  PubMed  Google Scholar 

  38. Lax SF (2004) Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 444:213–223

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Chicago, 900 E, 57th Street, KCBD, HO 8, 8115C, Chicago, IL, 60637, USA

    Dominique Sighoko

Authors
  1. Dominique Sighoko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dominique Sighoko.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 419 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sighoko, D. Ethnic and geographic variations in corpus uteri cancer burden: evidence based on data from 29 states and the District of Columbia. CI5 IX, X and SEER data (1998–2010). Cancer Causes Control 25, 1197–1209 (2014). https://doi.org/10.1007/s10552-014-0425-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-014-0425-z

Keywords

Search

Navigation